FBLG
Price
$0.95
Change
+$0.01 (+1.06%)
Updated
Nov 9 closing price
Capitalization
6.56M
3 days until earnings call
Intraday BUY SELL Signals
SLXN
Price
$0.12
Change
-$0.03 (-20.00%)
Updated
Nov 9 closing price
Capitalization
827.37K
One day until earnings call
Intraday BUY SELL Signals
Interact to see
Advertisement

FBLG vs SLXN

FBLG vs SLXN Comparison Chart in %
loading
loading
View a ticker or compare two or three
VS
FBLG vs. SLXN commentary
Nov 10, 2026

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is FBLG is a StrongBuy and SLXN is a Hold.

Interact to see
Advertisement
SUMMARIES
A.I.Advisor
a Summary for FBLG with price predictions
Nov 09, 2026

FBLG's MACD Histogram just turned positive

The Moving Average Convergence Divergence (MACD) for FBLG turned positive on October 27, 2026. Looking at past instances where FBLG's MACD turned positive, the stock continued to rise in 23 of 24 cases over the following month. The odds of a continued upward trend are 90%.

Price Prediction Chart

Technical Analysis (Indicators)

Bullish Trend Analysis

The RSI Oscillator points to a transition from a downward trend to an upward trend -- in cases where FBLG's RSI Oscillator exited the oversold zone, 22 of 27 resulted in an increase in price. Tickeron's analysis proposes that the odds of a continued upward trend are 81%.

The Stochastic Oscillator suggests the stock price trend may be in a reversal from a downward trend to an upward trend. 31 of 35 cases where FBLG's Stochastic Oscillator exited the oversold zone resulted in an increase in price. Tickeron's analysis proposes that the odds of a continued upward trend are 89%.

The Momentum Indicator moved above the 0 level on November 09, 2026. You may want to consider a long position or call options on FBLG as a result. In 35 of 49 past instances where the momentum indicator moved above 0, the stock continued to climb. The odds of a continued upward trend are 71%.

Following a +6.45% 3-day Advance, the price is estimated to grow further. Considering data from situations where FBLG advanced for three days, in 104 of 128 cases, the price rose further within the following month. The odds of a continued upward trend are 81%.

FBLG may jump back above the lower band and head toward the middle band. Traders may consider buying the stock or exploring call options.

Bearish Trend Analysis

The 10-day moving average for FBLG crossed bearishly below the 50-day moving average on October 06, 2026. This indicates that the trend has shifted lower and could be considered a sell signal. In 5 of 5 past instances when the 10-day crossed below the 50-day, the stock continued to move higher over the following month. The odds of a continued downward trend are 90%.

Following a 3-day decline, the stock is projected to fall further. Considering past instances where FBLG declined for three days, the price rose further in 50 of 62 cases within the following month. The odds of a continued downward trend are 90%.

The Aroon Indicator for FBLG entered a downward trend on November 04, 2026. This could indicate a strong downward move is ahead for the stock. Traders may want to consider selling the stock or buying put options.

Fundamental Analysis (Ratings)

The Tickeron Valuation Rating of 61 (best 1 - 100 worst) indicates that the company is fair valued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (1.414) is normal, around the industry mean (3.498). P/E Ratio (-0.185) is within average values for comparable stocks, (-1.193). Projected Growth (PEG Ratio) (0.000) is also within normal values, averaging (9.059). Dividend Yield (0.000) settles around the average of (130.981) among similar stocks. P/S Ratio (0.000) is also within normal values, averaging (440.869).

The Tickeron PE Growth Rating for this company is 73 (best 1 - 100 worst), pointing to worse than average earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.

The Tickeron Price Growth Rating for this company is 77 (best 1 - 100 worst), indicating slightly worse than average price growth. FBLG’s price grows at a lower rate over the last 12 months as compared to S&P 500 index constituents.

The Tickeron SMR rating for this company is 100 (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.

The Tickeron Profit vs. Risk Rating rating for this company is 100 (best 1 - 100 worst), indicating that the returns do not compensate for the risks. FBLG’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 93, placing this stock worse than average.

A.I.Advisor
a Summary for SLXN with price predictions
Nov 09, 2026

SLXN in -14.12% downward trend, sliding for three consecutive days on October 29, 2026

Moving lower for three straight days is viewed as a bearish sign. Keep an eye on this stock for future declines. Considering data from situations where SLXN declined for three days, in 186 of 202 cases, the price declined further within the following month. The odds of a continued downward trend are 90%.

Price Prediction Chart

Technical Analysis (Indicators)

Bearish Trend Analysis

The Aroon Indicator for SLXN entered a downward trend on November 09, 2026. This could indicate a strong downward move is ahead for the stock. Traders may want to consider selling the stock or buying put options.

Bullish Trend Analysis

The RSI Indicator entered the oversold zone -- be on the watch for SLXN's price rising or consolidating in the future. That's also the time to consider buying the stock or exploring call options.

The Stochastic Oscillator shows that the ticker has stayed in the oversold zone for 7 days. The price of this ticker is presumed to bounce back soon, since the longer the ticker stays in the oversold zone, the more promptly an upward trend is expected.

Following a +3.51% 3-day Advance, the price is estimated to grow further. Considering data from situations where SLXN advanced for three days, in 58 of 98 cases, the price rose further within the following month. The odds of a continued upward trend are 59%.

SLXN may jump back above the lower band and head toward the middle band. Traders may consider buying the stock or exploring call options.

Fundamental Analysis (Ratings)

The Tickeron Valuation Rating of 85 (best 1 - 100 worst) indicates that the company is significantly overvalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (18.804) is normal, around the industry mean (3.498). P/E Ratio (-0.007) is within average values for comparable stocks, (-1.193). Projected Growth (PEG Ratio) (0.000) is also within normal values, averaging (9.059). Dividend Yield (0.000) settles around the average of (130.981) among similar stocks. P/S Ratio (0.000) is also within normal values, averaging (440.869).

The Tickeron Price Growth Rating for this company is 97 (best 1 - 100 worst), indicating slightly worse than average price growth. SLXN’s price grows at a lower rate over the last 12 months as compared to S&P 500 index constituents.

The Tickeron PE Growth Rating for this company is 98 (best 1 - 100 worst), pointing to worse than average earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.

The Tickeron SMR rating for this company is 100 (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.

The Tickeron Profit vs. Risk Rating rating for this company is 100 (best 1 - 100 worst), indicating that the returns do not compensate for the risks. SLXN’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 93, placing this stock worse than average.

TECHNICAL ANALYSIS
Technical Analysis
FBLGSLXN
RSI
ODDS (%)
Bullish Trend 1 day ago
81%
Bullish Trend 1 day ago
81%
Stochastic
ODDS (%)
Bullish Trend 1 day ago
89%
Bullish Trend 1 day ago
56%
Momentum
ODDS (%)
Bullish Trend 1 day ago
71%
N/A
MACD
ODDS (%)
Bullish Trend 1 day ago
90%
N/A
TrendWeek
ODDS (%)
Bullish Trend 1 day ago
79%
Bearish Trend 1 day ago
72%
TrendMonth
ODDS (%)
Bearish Trend 1 day ago
90%
Bearish Trend 1 day ago
81%
Advances
ODDS (%)
Bullish Trend 7 days ago
81%
Bullish Trend 6 days ago
59%
Declines
ODDS (%)
Bearish Trend 4 days ago
90%
Bearish Trend 12 days ago
90%
BollingerBands
ODDS (%)
Bullish Trend 1 day ago
90%
Bullish Trend 1 day ago
67%
Aroon
ODDS (%)
Bearish Trend 1 day ago
90%
Bearish Trend 1 day ago
86%
COMPARISON
Comparison
Nov 10, 2026
Stock price -- (FBLG: $0.94 vs. SLXN: $0.12)
Brand notoriety: FBLG and SLXN are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: FBLG: 21% vs. SLXN: 13%
Market capitalization -- FBLG: $6.56M vs. SLXN: $827.37K
FBLG [@Biotechnology] is valued at $6.56M. SLXN’s [@Biotechnology] market capitalization is $827.37K. The market cap for tickers in the [@Biotechnology] industry ranges from $58 to $138.67B. The average market capitalization across the [@Biotechnology] industry is $2.23B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is overvalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

FBLG’s FA Score shows that 0 FA rating(s) are green while SLXN’s FA Score has 0 green FA rating(s).

  • FBLG’s FA Score: 0 green, 5 red.
  • SLXN’s FA Score: 0 green, 5 red.
According to our system of comparison, FBLG is a better buy in the long-term than SLXN.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

FBLG’s TA Score shows that 5 TA indicator(s) are bullish while SLXN’s TA Score has 4 bullish TA indicator(s).

  • FBLG’s TA Score: 5 bullish, 4 bearish.
  • SLXN’s TA Score: 4 bullish, 2 bearish.
According to our system of comparison, SLXN is a better buy in the short-term than FBLG.

Price Growth

FBLG (@Biotechnology) experienced а +1.35% price change this week, while SLXN (@Biotechnology) price change was -16.45% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +2.97%. For the same industry, the average monthly price growth was -8.33%, and the average quarterly price growth was +85.08%.

Reported Earning Dates

SLXN is expected to report earnings on Nov 11, 2026.

Industries' Descriptions

@Biotechnology (+2.97% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

View a ticker or compare two or three
Interact to see
Advertisement

FBLG and

Correlation & Price change

A.I.dvisor indicates that over the last year, FBLG has been loosely correlated with PEPG. These tickers have moved in lockstep 37% of the time. This A.I.-generated data suggests there is some statistical probability that if FBLG jumps, then PEPG could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To FBLG
1D Price
Change %
FBLG100%
+0.79%
PEPG - FBLG
37%
Loosely correlated
-3.24%
ATOS - FBLG
29%
Poorly correlated
+0.47%
ZNTL - FBLG
28%
Poorly correlated
+1.16%
CELC - FBLG
28%
Poorly correlated
+5.36%
REVB - FBLG
27%
Poorly correlated
+4.90%
More
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
ASTS36.894.56
+14.10%
AST SpaceMobile
MEGL0.140.02
+13.18%
Magic Empire Global Limited
SLSN0.900.04
+5.06%
Solesence Inc
BOC13.730.12
+0.88%
Boston Omaha Corp
BCRX7.63-0.06
-0.78%
BioCryst Pharmaceuticals